Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups
Kim E.M. van Kessel(Erasmus University Rotterdam), Ellen C. Zwarthoff(Erasmus MC), Niels Harving(Aalborg University Hospital), Kerstin Junker(Universitätsklinikum des Saarlandes), Marcus Horstmann(Friedrich Schiller University Jena), Tobias Maurer(Universität Hamburg), Núria Malats(Spanish National Cancer Research Centre), Per‐Uno Malmström(Uppsala University), Bastian Keck(Friedrich-Alexander-Universität Erlangen-Nürnberg), Torben F. Ørntoft, Naeromy Y.C. Welvaart(Erasmus MC Cancer Institute), Lars Dyrskjøt(Aarhus University Hospital), Astrid Petersen(Aalborg University Hospital), Gregers G. Hermann(Frederiksberg Hospital), Francisco X. Real(Universitat Pompeu Fabra), Karin Mogensen(Frederiksberg Hospital), Kirstin A. van der Keur(Erasmus MC Cancer Institute), Ulrika Segersten(Uppsala University), Joost L. Boormans(Erasmus MC), Ferrán Algaba(Puigvert Foundation), Willemien Beukers(Erasmus University Rotterdam), Jørgen Bjerggaard Jensen(University Psychiatric Hospital), Marc‐Oliver Grimm(Klinik und Poliklinik für Urologie), Arndt Hartmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Tatjana Simić(University of Belgrade)
Cited by 92
Related Papers
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
|JAMA Oncology|2019|992
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654